Thomas Hartung, MD

Thomas Hartung, MD, PhD, steers the revolution in toxicology to move away from 50+ year-old animal tests to organoid cultures and the use of artificial intelligence.

His research interests are: toxicology; pharmacology; infectious disease; alternatives to animal testing; microphysiological systems; cell culture; validation; pyrogen testing; big data; artificial intelligence; metabolomics; developmental neurotoxicity; mini-brains